Skip to content

Clinical trials

Phase 1 Lymphoma, T-Cell, Peripheral trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Phase: Phase 1 Country / region: Australia Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20181
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation1
Peter MacCallum Cancer Centre, Australia1
Taiho Oncology, Inc.1
Therapeutic Advances in Childhood Leukemia Consortium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral4
Lymphoma, Non-Hodgkin2
Lymphoma, T-Cell, Cutaneous2
Recurrence2
Carcinoma, Renal Cell1
Hematologic Neoplasms1
Hodgkin Disease1
Leukemia1
Lymphoma, Large B-Cell, Diffuse1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.